Latest News and Press Releases
Want to stay updated on the latest news?
-
BERNARDSVILLE, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader in Visual Biology for drug discovery, will showcase its Lightning AI platform at the 3rd annual...
-
BERNARDSVILLE, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, today announced its participation in the Society for Medicines Research’s...
-
BERNARDSVILLE, N.J., March 07, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, today announced their participation in the upcoming RNA Leaders Europe...
-
BERNARDSVILLE, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, announced today positive preclinical data of its lung fibrosis candidate. This...
-
BERNARDSVILLE, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, today announced their participation in the upcoming 6th Annual...
-
BERNARDSVILLE, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, announced its third webinar, a part of their exclusive LightON...
-
BERNARDSVILLE, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.bio leading developer of the mRNA Lightning platform at the intersection of mRNA biology and AI, announced its second...
-
BERNARDSVILLE, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven...
-
BERNARDSVILLE, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven...
-
BERNARDSVILLE, N.J., April 10, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven...